Patent · US Expired

Antibodies to human IL-8 type B receptor

US5440021A · kind A · utility

138Cited by

0References

7Claims

0Family size

Inventors

Anan Chuntharapai · Daly City, US
Caroline Hebert · San Francisco, US
Kyung Jin Kim · Los Altos, US
James Lee · Dongguan, CN

Key dates

Filing date	Feb 25, 1994
Grant date	Aug 8, 1995
Priority date	—
Expiry date	Feb 25, 2014

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

cDNAs encoding a class of receptors, including the IL-8 type B receptor, have been identified in human tissue. Recombinantly produced IL-8 type B receptor is used in the preparation and purification of antibodies capable of binding to the receptor, and in diagnostic assays. The antibodies are advantageously used in the prevention and treatment of inflammatory conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.